Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Wobser

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Plos One|January 30, 2014
p53 regulation by TRP2 is not pervasive in melanomaRoland Houben, Corinna P Schmid, Melissa Maier, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 26, 2024
Practical recommendations for therapy and monitoring of mogamulizumab patients in GermanyChalid Assaf, Nina Booken, Edgar Dippel, et al.
Acta Dermato-Venereologica|November 10, 2016
Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr-Virus-associated T-cell Lymphoproliferation with Subsequent Development of Aggressive NK/T-cell LymphomaAtiye Toksoy, Susanne Strifler, Sandrine Benoit, et al.
Oncotarget|January 10, 2018
Copy number variations in atypical fibroxanthomas and pleomorphic dermal sarcomasDoris Helbig, Alexander Quaas, Cornelia Mauch, et al.
Dermatology (Basel, Switzerland)|September 2, 2021
Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma NetworkChristoph Blazejak, Rene Stranzenbach, Janika Gosman, et al.
Cancers|July 26, 2020
Merkel Cell Polyomavirus T Antigens Induce Merkel Cell-Like Differentiation in GLI1-Expressing Epithelial CellsThibault Kervarrec, Mahtab Samimi, Sonja Hesbacher, et al.
Cancer Immunology, Immunotherapy : CII|May 9, 2012
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanomaJürgen C Becker, Mads H Andersen, Valeska Hofmeister-Müller, et al.
Cancers|January 10, 2026
Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma NetworkChristoph Blazejak, Mathias Oymanns, René Stranzenbach, et al.
Blood|May 22, 2023
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 studyJan P Nicolay, Susanne Melchers, Jana D Albrecht, et al.
Anticancer Research|October 3, 2014
STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoidesSimon Fredholm, Lise Mette R Gjerdrum, Andreas Willerslev-Olsen, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Plos One|January 30, 2014
p53 regulation by TRP2 is not pervasive in melanomaRoland Houben, Corinna P Schmid, Melissa Maier, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 26, 2024
Practical recommendations for therapy and monitoring of mogamulizumab patients in GermanyChalid Assaf, Nina Booken, Edgar Dippel, et al.
Acta Dermato-Venereologica|November 10, 2016
Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr-Virus-associated T-cell Lymphoproliferation with Subsequent Development of Aggressive NK/T-cell LymphomaAtiye Toksoy, Susanne Strifler, Sandrine Benoit, et al.
Oncotarget|January 10, 2018
Copy number variations in atypical fibroxanthomas and pleomorphic dermal sarcomasDoris Helbig, Alexander Quaas, Cornelia Mauch, et al.
Dermatology (Basel, Switzerland)|September 2, 2021
Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma NetworkChristoph Blazejak, Rene Stranzenbach, Janika Gosman, et al.
Cancers|July 26, 2020
Merkel Cell Polyomavirus T Antigens Induce Merkel Cell-Like Differentiation in GLI1-Expressing Epithelial CellsThibault Kervarrec, Mahtab Samimi, Sonja Hesbacher, et al.
Cancer Immunology, Immunotherapy : CII|May 9, 2012
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanomaJürgen C Becker, Mads H Andersen, Valeska Hofmeister-Müller, et al.
Cancers|January 10, 2026
Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma NetworkChristoph Blazejak, Mathias Oymanns, René Stranzenbach, et al.
Blood|May 22, 2023
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 studyJan P Nicolay, Susanne Melchers, Jana D Albrecht, et al.
Anticancer Research|October 3, 2014
STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoidesSimon Fredholm, Lise Mette R Gjerdrum, Andreas Willerslev-Olsen, et al.
Pageof 11